Literature DB >> 19102880

[Recommendation of the application of universal definition of myocardial infarction in China.].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19102880

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  5 in total

1.  Analysis of the risk factors and characteristics of coronary artery disease of Han, Uygur and Kazak patients with acute myocardial infarction in Xinjiang district.

Authors:  Jiao Wang; Zhi-Qiang Liu; Peng-Yi He; Yu-Chun Yang; Lei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Trends in cardiac biomarker testing in China for patients with acute myocardial infarction, 2001 to 2011: China PEACE-retrospective AMI study.

Authors:  Lijuan Zhan; Frederick A Masoudi; Xi Li; Shuang Hu; Arjun K Venkatesh; John A Spertus; Zhenqiu Lin; Nihar R Desai; Jing Li; Harlan M Krumholz; Lixin Jiang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

3.  Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.

Authors:  Hong Li; Ximing Li; Hongjun Ma; Yiran Wang; Naikuan Fu; Dongxia Jin; Hongliang Cong
Journal:  ScientificWorldJournal       Date:  2014-01-29

Review 4.  Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis.

Authors:  Pengda Liao; Lei Wang; Liheng Guo; Ruixiang Zeng; Juming Huang; Minzhou Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-14       Impact factor: 2.629

5.  Systematic review of compound danshen dropping pill: a chinese patent medicine for acute myocardial infarction.

Authors:  Jing Luo; Hao Xu; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.